• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Country breakout session highlights.

作者信息

Ghezzi Angelo, Filli Linard, Solaro Claudio, Mekies Claude, Landete Lamberto, Lycke Jan

机构信息

Neurologia 2, Centro Studi Sclerosi Multipla, Gallarate Hospital, Gallarate, Italy.

Gait Research Laboratory, Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

出版信息

Neurodegener Dis Manag. 2016 Dec;6(6s):41-44. doi: 10.2217/nmt-2016-0055.

DOI:10.2217/nmt-2016-0055
PMID:27874497
Abstract

At the 2016 MS Experts Summit, country-relevant aspects pertaining to the management of symptoms and disability in multiple sclerosis (MS), with emphasis on those associated with spasticity, were explored in interactive country breakout sessions chaired by selected MS experts. Attendees had the opportunity to review and discuss topics in their own native language. After feedback from each session leader, key messages were collated and presented in a Plenary Session by Summit chair, Professor Angelo Ghezzi. Topics at this year's Summit included: gait tracking (Germany/Switzerland); the Care Alliance against MS spasticity (Italy); MS spasticity and associated symptoms (France); improvement in MS symptoms and functionality and patients' independence (Spain); Swedish MS guidelines (Sweden/Rest of World).

摘要

相似文献

1
Country breakout session highlights.
Neurodegener Dis Manag. 2016 Dec;6(6s):41-44. doi: 10.2217/nmt-2016-0055.
2
Country break-out session highlights.各国分组会议要点
Neurodegener Dis Manag. 2015;5(6 Suppl):31-7. doi: 10.2217/nmt.15.58.
3
Break-out session highlights.
Neurodegener Dis Manag. 2017 Nov;7(6s):45-49. doi: 10.2217/nmt-2017-0042.
4
What is new in multiple sclerosis spasticity research? Poster session highlights.多发性硬化痉挛研究有哪些新进展?壁报展示亮点
Neurodegener Dis Manag. 2016 Dec;6(6s):45-47. doi: 10.2217/nmt-2016-0056.
5
Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.多发性硬化症痉挛的临床病例回顾与海报展示:主要成果与亮点
Eur Neurol. 2014;72 Suppl 1:15-9. doi: 10.1159/000367619. Epub 2014 Sep 26.
6
A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.一项关于巴氯芬和 THC:CBD 口腔喷雾剂对多发性硬化相关痉挛性步行障碍影响的综述。
Expert Rev Neurother. 2018 Oct;18(10):785-791. doi: 10.1080/14737175.2018.1510772. Epub 2018 Sep 20.
7
What's new in multiple sclerosis spasticity research? Poster session highlights.多发性硬化痉挛研究有哪些新进展?壁报展示亮点
Neurodegener Dis Manag. 2017 Nov;7(6s):51-53. doi: 10.2217/nmt-2017-0043.
8
Evolution of multiple sclerosis spasticity-associated symptoms: latest data.多发性硬化痉挛相关症状的演变:最新数据
Neurodegener Dis Manag. 2016 Dec;6(6s):9-12. doi: 10.2217/nmt-2016-0047.
9
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).物理治疗干预对使用大麻二酚/四氢大麻酚口溶膜(nabiximols,THC:CBD 或黏膜喷雾)治疗的多发性硬化相关痉挛患者的影响。
PLoS One. 2019 Jul 30;14(7):e0219670. doi: 10.1371/journal.pone.0219670. eCollection 2019.
10
Multiple sclerosis symptom management.多发性硬化症症状管理
Expert Rev Neurother. 2007 Sep;7(9):1213-22. doi: 10.1586/14737175.7.9.1213.